The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combination of radiomic and biomarker signatures as exploratory objective in a phase II trial with intratumoral BO-112 plus pembrolizumab for advanced melanoma.
 
Ivan Marquez-Rodas
Consulting or Advisory Role - Amgen; AstraZeneca; Bioncotech; Bristol-Myers Squibb; Incyte; Merck Serono; MSD; Novartis; Pierre Fabre; Regeneron; Roche; Sanofi
Travel, Accommodations, Expenses - Bioncotech; Bristol-Myers Squibb; MSD; Roche
 
Stéphane Dalle
Employment - Sanofi Pasteur (I)
Stock and Other Ownership Interests - Sanofi (I)
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); MSD (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); MSD (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Eduardo Castanon
Consulting or Advisory Role - AstraZeneca Spain; BeiGene
Speakers' Bureau - AstraZeneca; BMSi; MSD Oncology; Roche
Travel, Accommodations, Expenses - AstraZeneca; BMSi; MSD; Roche
 
Miguel F. Sanmamed
Consulting or Advisory Role - Numab; Pieris Pharmaceuticals
Speakers' Bureau - BMSi; MSD
Travel, Accommodations, Expenses - AstraZeneca; BMSi; Roche
 
Ana Maria Arance
Consulting or Advisory Role - BMSi; Merck Serono; MSD; Novartis; Roche; Sanofi
Travel, Accommodations, Expenses - BMSi; Merck Serono; MSD; Novartis; Roche; Sanofi
 
Pablo Cerezuela-Fuentes
Consulting or Advisory Role - Novartis; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis; Rovi; Sanofi/Regeneron
Travel, Accommodations, Expenses - Merck; Novartis; Roche
 
Roberto Martin Huertas
No Relationships to Disclose
 
Juan Francisco Rodríguez-Moreno
Consulting or Advisory Role - Amgen; BMSi; Janssen; Novartis; Rainier Therapeutics
Speakers' Bureau - AstraZeneca; BMSi; Janssen; MSD; Novartis; Pfizer; Roche
Research Funding - Abbvie; Amgen; Aprea Therapeutics; Astellas Oncology; AstraZeneca; Bayer; BMSi; Eisai; GlaxoSmithKline; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - Astellas Oncology; BMSi; MSD; Novartis; Pfizer; Roche
 
Maria Gonzalez-Cao
Speakers' Bureau - BMSi; Novartis; Roche
 
Eva Muñoz-Couselo
Consulting or Advisory Role - BMSi; Highlight Therapeutics; Merck Serono; MSD; Roche
Travel, Accommodations, Expenses - BMSi; MSD; Roche
 
Juan Martin-Liberal
Consulting or Advisory Role - Bristol-Myers Squibb; Highlight Therapeutics; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Pierre Fabre; Roche
 
Delvys Rodriguez-Abreu
Consulting or Advisory Role - AstraZeneca Spain; Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Ángel Alberich-Bayarri
Other Relationship - Highlight Therapeutics
 
Irene Mayorga-Ruiz
Other Relationship - Highlight Therapeutics
 
Miguel Angel Molina Vila
Employment - Pangaea Oncology
Research Funding - AstraZeneca (Inst); In3Bio (Inst); Merck Serono (Inst)
 
Ruth Román
Other Relationship - Highlight Therapeutics
 
Marya F. Chaney
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Javier Sánchez López
Employment - Highlight Therapeutics; Lilly
 
Sonia Maciá
Employment - Highlight Therapeutics
 
Marisol Quintero
Employment - Highlight Therapeutics